Myrtelle logo — The future of genetic therapeutics

Myrtelle

The future of genetic therapeutics

Founded 2020 United States Wakefield, United States 9 employees Series Unknown Biotechnology, Health Care

General Information

Company Name Myrtelle
Founded Year 2020
Location United States Wakefield, United States +1
Employees 9
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Myrtelle moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Myrtelle

Myrtelle is a biotechnology startup with a focus on health care, founded in 2020. The company's slogan, "The future of genetic therapeutics," indicates its commitment to revolutionizing the treatment of neurological diseases through gene therapy. Myrtelle's initial focus is on developing a gene therapy treatment for Canavan disease, showcasing its dedication to addressing devastating disorders of the central nervous system. The company has established a strong presence on social media, utilizing these platforms to build a community around Canavan disease and Myrtelle's groundbreaking initiatives. However, it's important to note that the information and discussions on Myrtelle's social media channels should not be considered as medical advice. Myrtelle emphasizes the importance of consulting health care professionals for personalized medical advice, clarifying that the content shared on their social media channels may not always be comprehensive, reliable, or up-to-date. Myrtelle maintains a neutral stance on opinions and statements expressed by others on their social media channels, as well as those linked to external websites. The company does not endorse or take responsibility for content outside of its official channels. Currently, there is no available information about Myrtelle's investment history or investors. However, considering the promising potential of gene therapy in addressing neurological diseases, Myrtelle presents an intriguing opportunity for potential investors seeking to contribute to the advancement of genetic therapeutics in the United States.

No funding data available for Myrtelle yet.

Get notified when Myrtelle raises funding

Myrtelle Alternatives & Competitors

Myrtelle vs

We pursue promising science to address some of the toughest challenges in autoimmune disease. Com...

Post Ipo Equity
256 employees
Biopharma, Biotechnology
Myrtelle vs

Let's see what is possible

21 employees
Financial Services, Wealth Management
Myrtelle vs
Lime Trading
Lime Trading United States

Power your strategy with technology built to give you control, precision, and flexibility

54 employees

FAQ About Myrtelle

The future of genetic therapeutics
Myrtelle was founded in 2020.
Myrtelle is headquartered in Wakefield, United States.
Myrtelle operates in the following industries: Biotechnology, Health Care.
Myrtelle has approximately 9 employees.
Top alternatives and competitors to Myrtelle include Aurinia Pharmaceuticals Inc., Cutler Investment Group, Lime Trading, Byrne Insurance Group, Hexavest. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Myrtelle and Aurinia Pharmaceuticals Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Myrtelle and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy